Showing results (41-50 of 85) with videos related to
Sort By:
Pageof 9
Journal of Drug Targeting|May 26, 2018
Recent advances in electrospun for drug delivery purposeMengyao Liu, Yanan Zhang, Siyu Sun, et al.International Journal of Pharmaceutics|January 23, 2021
Galactosamine-modified PEG-PLA/TPGS micelles for the oral delivery of curcuminSiyu Sun, Xiyou Du, Manfei Fu, et al.Expert Opinion on Drug Delivery|February 15, 2022
Tumor microenvironment-responsive size-switchable drug delivery nanosystemsYue Hu, Shan Gao, Abdur Rauf Khan, et al.Journal of Colloid and Interface Science|June 26, 2019
Pluronic F127-functionalized molybdenum oxide nanosheets with pH-dependent degradability for chemo-photothermal cancer therapyYujuan Chen, Abdur Rauf Khan, Dexin Yu, et al.Journal of Drug Targeting|January 24, 2019
Advances in curcumin-loaded nanopreparations: improving bioavailability and overcoming inherent drawbacksYanan Zhang, Abdur Rauf Khan, Manfei Fu, et al.Journal of Colloid and Interface Science|April 26, 2021
Redox-responsive hyaluronic acid-based nanoparticles for targeted photodynamic therapy/chemotherapy against breast cancerRujuan Wang, Haotong Yang, Abdur Rauf Khan, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 24, 2020
Photo-triggered self-destructive ROS-responsive nanoparticles of high paclitaxel/chlorin e6 co-loading capacity for synergetic chemo-photodynamic therapyXiaoye Yang, Xiaoqun Shi, Yanan Zhang, et al.ACS Nano|June 5, 2023
A Vanadium-Based Nanoplatform Synergizing Ferroptotic-like Therapy with Glucose Metabolism Intervention for Enhanced Cancer Cell Death and Antitumor ImmunityYu Zhang, Xiyou Du, Zhijing He, et al.Acta Pharmaceutica Sinica. B|September 30, 2021
Combination therapy with miR34a and doxorubicin synergistically inhibits Dox-resistant breast cancer progression via down-regulation of Snail through suppressing Notch/NF-κB and RAS/RAF/MEK/ERK signaling pathwayXiaoxia Yang, Pengfei Shang, Bingfang Yu, et al.Journal of Drug Targeting|December 21, 2022
Research progress of exosomes as drug carriers in cancer and inflammationQixiang Feng, Yu Zhang, Yuelin Fang, et al.Pageof 9